Filtern
Erscheinungsjahr
Dokumenttyp
- Zeitschriftenartikel (25)
- Vortrag (13)
- Posterpräsentation (6)
Schlagworte
- Deoxynivalenol (3)
- Glucuronidation (3)
- Phase I metabolism (3)
- Cyanotoxin (2)
- Cylindrospermopsin (2)
- ERM (2)
- Food (2)
- Fusarium mycotoxins (2)
- HPLC-MS/MS (2)
- Hydroxylation (2)
- Masked mycotoxins (2)
- Metabolism (2)
- Mycotoxins (2)
- Quantification (2)
- 3,4,4'-trichlorocarbanilide (1)
- Acetyl-DON (1)
- Alpha-zearalenol (1)
- Analytical standards (1)
- Analytik (1)
- Bioaccumulation (1)
- Biosynthesis (1)
- Bran (1)
- Brassicaceae (1)
- Brominated flame retardant (1)
- Caco-2 cells (1)
- Cis-ZEN (1)
- Claviceps purpurea (1)
- Cleanup effectiveness (1)
- Conjugation (1)
- Cyanobacterial toxin (1)
- Cyanotoxine (1)
- Cytochrome P-450 (1)
- Cytochromes (1)
- DON-3-glucoside (1)
- Deoxynivalenol (DON) (1)
- Depletion kinetics (1)
- Detoxification (1)
- Diaporthe toxica (1)
- Dynamic light scattering (1)
- Ergotamine (1)
- Ergotoxine (1)
- Exposure source (1)
- Fermentation (1)
- Field-flow fractionation (1)
- Flour extraction (1)
- Food fermentation (1)
- Food safety (1)
- Germination (1)
- HPLC-FLD (1)
- HRMS (1)
- Harmful algal bloom (1)
- HepaRG cells (1)
- Hepatic metabolism (1)
- Human health (1)
- Human recombinant UGT (1)
- In vitro digestion (1)
- Inter-species comparison (1)
- Isotopic labeled internal standard (1)
- LC-HRMS (1)
- LC-MS/MS (1)
- Lebensmittel (1)
- Liver tissue fractions (1)
- Lupins (1)
- Malting (1)
- Masked mycotoxin (1)
- Mass spectrometry (1)
- Metabolites (1)
- Microbial conversion (1)
- Microsomes (1)
- Modified mycotoxins (1)
- Multi-mycotoxin determination (1)
- Mycotoxin biotransformation (1)
- Mycotoxins and fungal metabolites (1)
- Mykotoxine (1)
- Nivalenol (1)
- Okadaic acid (1)
- Phase II metabolism (1)
- Phomopsin A (1)
- Plant systemic availability (1)
- Quality assurance (1)
- Rapid and validated methods (1)
- Recovery rate (1)
- Referenzmaterial (1)
- Regulations (1)
- Rhizopus and Aspergillus oryzae (1)
- Rye (1)
- SIDA (1)
- Sampling (1)
- Silver nanoparticles (1)
- Small-angle X-ray scattering (1)
- Spin-columns (1)
- Stability (1)
- Stable isotope dilution assay (1)
- Surface water (1)
- Trichothecene (1)
- UPLC-MS/MS (1)
- Uridine-diphosphoglucuronyltransferases (UGT) (1)
- Vegetable plants (1)
- Zearalenone (1)
- Zearalenone sulfate (1)
- Zearalenone-sulfate (1)
- a-zearalenol (1)
Organisationseinheit der BAM
Eingeladener Vortrag
- nein (13)
In vitro metabolism of the cyanotoxin cylindrospermopsin in HepaRG cells and liver tissue fractions
(2016)
No evidence for phase I metabolites of the cyanotoxin cylindrospermopsin (CYN) was given using HepaRG cells and different liver tissue fractions when studying metabolic conversion. Although the application of ketoconazole, a CYP3A4 inhibitor, led to a decreased cytotoxicity of CYN, no metabolites were detected applying high resolution mass spectrometry. Quantification of non-modified CYN led to recovery rates of almost 100%. Consequently, reduction of CYN toxicity in the presence of metabolism inhibiting agents must be attributed to alternative pathways.
Recently, there has been a rise in freshwater harmful algal blooms (HABs) globally, as well as increasing aquaculture practices. HABs can produce cyanotoxins, many of which are hepatotoxins. An ultra-performance liquid chromatography tandem mass spectrometry method was developed and validated for nine cyanotoxins across three classes including six microcystins, nodularin, cylindrospermopsin and anatoxin-a. The method was used to analyse free cyanotoxin(s) in muscle (n = 34), liver (n = 17) and egg (n = 9) tissue samples of 34 fish sourced from aquaculture farms in Southeast Asia. Conjugated microcystin was analysed by Lemieux oxidation to ascertain the total amount of microcystin present in muscle. Some tilapia accumulated free microcystin-LR in the muscle tissue at a mean of 15.45 μg/kg dry weight (dw), with total microcystin levels detected at a mean level of 110.1 μg/kg dw, indicating that the amount of conjugated or masked microcystin present in the fish muscle accounted for 85% of the total. Higher levels of cyanotoxin were detected in the livers, with approximately 60% of those tested being positive for microcystin-LR and microcystin-LF, along with cylindrospermopsin. Two fish from one of the aquaculture farms contained cylindrospermopsin in the eggs; the first time this has been reported. The estimated daily intake for free and total microcystins in fish muscle tissue was 2 and 14 times higher, respectively, than the tolerable daily intake value. This survey presents the requirement for further monitoring of cyanotoxins, including masked microcystins, in aquaculture farming in these regions and beyond, along with the implementation of guidelines to safeguard human health.
Orally ingested nanoparticles may overcome the gastrointestinal barrier, reach the circulatory system, be distributed in the organism and cause adverse health effects. However, ingested nanoparticles have to pass through different physicochemical environments, which may alter their properties before they reach the intestinal cells. In this study, silver nanoparticles are characterised physicochemically during the course of artificial digestion to simulate the biochemical processes occurring during digestion. Their cytotoxicity on intestinal cells was investigated using the Caco-2 cell model. Using field-flow fractionation combined with dynamic light scattering and small-angle X-ray scattering, the authors found that particles only partially aggregate as a result of the digestive process. Cell viabilities were determined by means of CellTiter-Blue® assay, 4',6-diamidino-2-phenylindole-staining and real-time impedance. These measurements reveal small differences between digested and undigested particles (1–100 µg/ml or 1–69 particles/cell). The findings suggest that silver nanoparticles may indeed overcome the gastrointestinal juices in their particulate form without forming large quantities of aggregates. Consequently, the authors presume that the particles can reach the intestinal epithelial cells after ingestion with only a slight reduction in their cytotoxic potential. The study indicates that it is important to determine the impact of body fluids on the nanoparticles of interest to provide a reliable interpretation of their nano-specific cytotoxicity testing in vivo and in vitro.